You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

serplulimab

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer Trial in Xi'an (dietary supplement, biological, drug)

Recruiting
  • Gastric Cancer
  • Taurine
  • +3 more
  • Xi'an, Shaanxi, China
    Tang-Du Hospital
Nov 7, 2023

Gastric Cancer Trial in Shanghai (Serplulimab, Trastuzuma, Chemotherapy)

Recruiting
  • Gastric Cancer
  • Serplulimab
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 27, 2023

Locally Advanced Pancreatic Cancer Trial in Guangzhou (Sulfatinib, Serplulimab, Albumin-paclitaxel)

Not yet recruiting
  • Locally Advanced Pancreatic Cancer
  • Guangzhou, Guangdong, China
    First Affiliated Hospital, Sun Yat-Sen University
Aug 10, 2023

Small-cell Lung Cancer Trial in Guangzhou (Serplulimab)

Recruiting
  • Small-cell Lung Cancer
  • Serplulimab
  • Guangzhou, Guangdong, China
    Guangdong Provincial Perople's Hospital
Jul 20, 2023

Serplulimab in 2L and Above Treatment of Cervical Cancer

Recruiting
  • Cervical Cancer
  • Serplulimab
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
May 30, 2023

Gastroesophageal Junction Adenocarcinoma Trial in Beijing (Serplulimab)

Recruiting
  • Gastroesophageal Junction Adenocarcinoma
  • Serplulimab
  • Beijing, China
    Peking Union Medical College Hospital
Jun 15, 2023

Colorectal Cancer Trial in Shanghai (serplulimab, Fruquintinib)

Not yet recruiting
  • Colorectal Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 13, 2023

Serplulimab,Gastric Cancer, Adjuvant Therapy Trial in Shanghai (Serplulimab, Docetaxel, S1)

Recruiting
  • Serplulimab,Gastric Cancer, Adjuvant Therapy
  • Serplulimab
  • +2 more
  • Shanghai, China
    Zhang Zizhen
Mar 3, 2023

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Proficient Mismatch Repair Trial in China (S1,

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +4 more
May 23, 2023

NSCLC Stage IV Trial (HLX26, Serplulimab, Pemetrexed)

Not yet recruiting
  • NSCLC Stage IV
  • (no location specified)
Mar 15, 2023

Extensive-stage Small-cell Lung Cancer Trial in China (serplulimab, Cisplatin, Carboplatin)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • serplulimab
  • +4 more
  • Shantou, Guangdong, China
  • +6 more
Mar 1, 2023

Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Jinan, Qingdao, Yantai (Serplulimab, Lenvatinib,

Not yet recruiting
  • Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
  • Serplulimab
  • +2 more
  • Jinan, Shandong, China
  • +5 more
Oct 16, 2022

Cervical Cancer Trial in China (Serplulimab, Bevacizumab)

Not yet recruiting
  • Cervical Cancer
  • Harbin, Heilongjiang, China
  • +3 more
Jun 29, 2022

Locally Advanced Colon Cancer Trial (Serplulimab, short-term radiotherapy, Oxaliplatin)

Not yet recruiting
  • Locally Advanced Colon Cancer
  • Serplulimab
  • +3 more
  • (no location specified)
Feb 16, 2023

Locally Advanced, NSCLC Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Locally Advanced
  • Non-small Cell Lung Cancer
  • Serplulimab
  • +5 more
  • Shanghai, China
    Shanghai Pulmonary Hospital
Mar 14, 2023

Malignant Ascites Trial (Serplulimab, Molgramostim, Hypofractionated radiotherapy/Sterotactic body radiotherapy)

Not yet recruiting
  • Malignant Ascites
  • Serplulimab
  • +2 more
  • (no location specified)
Aug 11, 2022